Therefore, we used available data from the Leukemia Mile Study15, 16, 17 and the BeatAML2.0 study18, 19 to confirm our data on increased ZIP10 (=SLC39A10) expression in AML patients. Here, SLC39A10 is linked to acute myeloid leukemia.